NREA        From Recognition to Action: Nurses’ Role in Early Alzheimer’s Disease & Emerging Therapies

CNE pts: 2

Sponsored by Eisai (HK) Co., Ltd

Objective:

To enhance the ability to recognise early Alzheimer’s disease by illustrating key clinical features, diagnostic pathways and treatment with anti-amyloid through real-world local cases sharing

Contents:

Understanding Alzheimer’s Disease

·         Epidemiology, Disease burden on patients, caregivers, healthcare system

·         Disease Continuum

·         Disease Pathophysiology

Diagnosis & Work-up

·         Clinical assessment (history, caregiver input)

·         Cognitive screening tools (MMSE, MoCA)

·         Biomarkers (p-tau, MRI, amyloid PET)

Current & Emerging Treatment Landscape

·         Traditional treatment - Symptomatic Treatment

·         Introduction to Disease-Modifying Therapy (Why early intervention matters)

·         Novel treatment - Anti-Amyloid Therapies

·         Clinical Benefits

·         Safety & Monitoring

Patient Journey & Nursing Support in Alzheimer’s Disease (Emotional Support, Patient & Caregiver Education, Caregiver Support)

·         Before Treatment: What Patients & Families Psychological State

·         At Diagnosis: Emotional Impact, Patient and Families Reaction & How to Discuss With Them When Making Decision

·         During Treatment Journey: Patient Experience And Psychological Changes Over Time (from early phase to long-term phase)

Practical Patient-Centered Case Discussion

·         AAT case sharing: How to communicate with Patients & Families

Speaker: Dr. Wong Ka Yau Raymond & Dr. Man Fung Kenneth Wong

Period: 12/10/2026 (Mon, total 1 session), 7:00 - 9:00pm

Venue:  6/F, Parkes Commercial Building, 29-31 Parkes Street, Jordan, Kowloon

Fee:     $200 (member)                $400 (non-member)